Brief: Oncodesign And Tiumbio Sign Collaboration Agreement For Research And Development Of Fibrosis Drug Candidates
Oct 21 (Reuters) - Oncodesign SA ALONC.PA :
* ONCODESIGN AND TIUMBIO SIGN COLLABORATION AGREEMENT FOR
RESEARCH
AND DEVELOPMENT OF FIBROSIS DRUG CANDIDATES
* AGREEMENT ALSO FORESEES OPTION FOR IN-LICENSING GLOBAL
DEVELOPMENT AND COMMERCIALIZATION RIGHTS FOR TIUMBIO
Source text for Eikon: ID:nBw60BZrya
Further company coverage: ALONC.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on TiumBio
See all newsBrief: TiumBio And Daewon Pharmaceutical Successfully Complete Phase 2 Clinical Trial Of 'Merigolix For Uterine Fibroids
Brief: TiumBio Presents Phase 1b Interim Results for TU2218 in Combination with Pembrolizumab
Brief: TiumBio Submits CTA For Phase 1b Clinical Trial Of TU7710
Brief: Tiumbio To Initiate Phase 2 Trial Of Tu2218 For Cancer
Brief: Tiumbio And Hansoh Pharma Announce Clinical Trial Approval Of 'HS-10518/TU2670' From NMPA In China